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Background: Marital status has been described to affect outcome in cardiovascular diseases, however its 
impact on patients undergoing transcatheter aortic valve implantation (TAVI) is unknown. We therefore 
aimed to assess the impact of marital status in patients undergoing TAVI.
Methods: Between 2011 and 2015, 779 patients undergoing transfemoral TAVI with known marital status 
were included in the analysis. The primary endpoint of the study was the composite of cardiac death and 
readmission for congestive heart failure (CHF) at one year. 
Results: Mean age was 80.7±5.9 years, 47.8% were female and median logistic EuroScore was 12.7% 
(8.13–19.39%). Forty-three point three percent of patients were not married. Compared to married 
patients, unmarried patients were older (82.4±5.5 vs. 79.5±5.8 years; P<0.001), more often female (73.3% vs. 
28.3%; P<0.001), presented with a higher logistic EuroScore [13.1% (9.5–21.5%) vs. 11.7% (7.0–18.5%); 
P<0.001], and more symptomatic with New York Heart Association functional class III/IV (69.7% vs. 60.6%; 
P=0.009). At one year the incidence of the primary endpoint was higher in unmarried patients (18.7% vs. 
12.0%; P=0.011) which was mainly driven by more admissions for CHF (14.1% vs. 7.8%; P=0.007). After 
multivariable adjustment, marital status was borderline significant regarding CHF (HR 0.61, 95% CI: 0.37–
1.02; P=0.06) but not the primary endpoint.
Conclusions: Unmarried patients undergoing TAVI showed a higher incidence of cardiac death or CHF 
at one year. Hence, marital status should be taken into account in patients with aortic stenosis subjected 
to TAVI. Whether closer monitoring and intensified medical follow-up improves outcomes remains to be 
investigated in future studies.
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Introduction
Transcatheter aortic valve implantation (TAVI) has been 
shown to be superior to surgical aortic valve replacement 
(SAVR) in high-risk patients (1) and non-inferior in 
intermediate-risk patients (2,3). Therefore, the use of this 
treatment option is rapidly increasing especially among an 
elderly, multimorbid patient population. With increasing 
operator experience, improved patient selection as well as 
continuous evolution of prosthetic valves and refinement of 
delivery systems, a considerable improvement in outcomes 
has been achieved with a reduction of 1-year mortality 
from 24% to 12% with older and newer generation devices 
(2,4). In addition to procedural factors, mortality rates are 
known to be influenced by age, higher pre-operative risk, 
alternative access sites (5,6).
Several baseline risk factors have been identified in 
patients undergoing TAVI, so far (7,8). Marital status has 
been associated with differences in survival and clinical 
outcomes for a variety of medical conditions including 
cardiovascular diseases (9-11). Results after cardiovascular 
surgery, interventions for acute coronary syndrome, 
elective percutaneous interventions, and cardiac bypass 
graft surgery have been shown to correlate with marital 
status (12-15). To date, the influence of marital status and 
its impact on prognosis in patients undergoing TAVI has 
not been evaluated. Therefore, we sought to investigate 
whether unmarried patients are at an increased risk for 
adverse outcome, i.e., at one year after TAVI compared to 
married patients.
Methods
Patient population
Between April 2011 and November 2015, 810 patients 
underwent transfemoral TAVI for severe aortic valve stenosis 
or bioprosthesis degeneration at the Klinik für Herz-und 
Kreislauferkrankungen, Deutsches Herzzentrum München, 
Munich, Germany. Of these, 779 patients (96.2%) had 
available information on marital status and formed the final 
study population. All patients were considered suitable for the 
procedure by an interdisciplinary Heart Team and provided 
written informed consent prior to the procedure and were 
included in the AVIATOR TAVI registry (NCT01390675; 
institutional ethics review board no. 5081/10). Data were 
prospectively collected according to the updated Valve 
Academic Research Consortium (VARC)-2 criteria (16). 
All procedures performed were in accordance with the 
ethical standards of the institutional and national research 
committee and with the 1964 Helsinki declaration and its 
later amendments or comparable ethical standards. 
Follow-up and definition of endpoints
Follow-up was obtained by direct patient contact at our 
outpatient clinic, by contacting the treating physician or 
by telephone, and censored at one year or last contact, 
respectively. Follow-up was complete in 99.1% of the final 
study population.
For the purpose of this analysis, patients were divided 
into two groups according to marital status at time of TAVI: 
married or in a stable relationship, henceforth “married”; 
and unmarried, which included divorced, separated, 
widowed and single patients.
The primary endpoint of the study was cardiac death or 
need for hospitalization for congestive heart failure (CHF) 
at one year. Secondary endpoints were all-cause and cardiac 
mortality, as well as re-hospitalization for CHF at one year.
Statistical analysis
Continuous variables are expressed as mean ± SD or as 
median (interquartile range) and were compared using 
the unpaired Student’s t-test or Mann-Whitney U test, as 
appropriate. Discrete variables were compared using the 
chi-square test or Fisher's exact test, as necessary. Survival 
distribution during follow-up was estimated using the 
Kaplan-Meier method and compared with the log-rank test. 
A Cox proportional regression model with computation 
of hazard ratios (HR) and 95% Confidence Intervals (CI) 
was used to assess the association of marital status with 
the primary endpoint. To avoid overfitting, selection of 
covariates in the multivariate Cox regression model was 
performed using the least absolute shrinkage and selection 
operator regression method after entering all baseline 
characteristics as candidates (R package “glmnet”, version 
2.0-13). The resulting variables for the multivariate Cox 
regression model were marital status, age, New York Heart 
Association (NYHA) III/IV, chronic obstructive pulmonary 
disease (COPD), glomerular filtration rate, peripheral 
artery disease, previous stroke, previous coronary artery 
bypass graft (CABG), SAVR, previous malignancy, previous 
pacemaker, as well as left ventricular ejection fraction 
(LVEF), aortic valve area, mean transvalvular gradient 
and pulmonary hypertension. Missing baseline data were 
imputed using the predictive mean matching function (R 
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package mice, version 2.46). Hosmer-Lemeshow test was 
used in a binomial logistic regression to evaluate whether 
expected and observed event rates in subgroups are well 
calibrated (Chi-square 3.6, P=0.89). The proportional 
hazards assumption was tested using the cox.zph function 
(R package “survival”, version 2.43-3) and revealed that 
the assumption of proportionality was not violated (marital 
status: rho 0.12363, Chi-square 1.14, P=0.29; global P=0.67).
To account for gender related differences on the effect 
of marital status a subgroup analysis was conducted for 
male and female patients. The selection of covariates for 
computing multivariate models for these subgroups were 
performed as described above.
A two-sided P value <0.05 was considered statistically 
significant for all analyses. IBM SPSS Statistics version 
24 (SPSS Inc., Chicago, IL, USA) and R (Version 3.4.3, 
R Foundation for Statistical Computing, Vienna, Austria) 
were employed.
Results
Patient population, and in-hospital outcome according to 
marital status
A total of 779 patients with known marital status underwent 
transfemoral TAVI and were included in the analysis. 
Mean age was 80.7±5.9 years, 47.8% were female and 
median logistic EuroScore was 12.7% (8.13–19.39%). 
Among the study population 56.7% were married or in a 
stable relationship at the time of procedure. Table 1 depicts 
baseline characteristics according to marital status, showing 
significant differences between the two groups. Compared to 
married patients, unmarried patients were older (82.4±5.5 vs. 
79.5±5.8 years; P<0.001), more often female (73.3% vs. 28.3%; 
P<0.001), and presented with a higher logistic EuroScore 
[13.1% (9.5–21.5%) vs. 11.7% (7.0–18.5%); P<0.001] 
reflecting a higher burden of comorbidities. Furthermore, 
patients in the unmarried group were more symptomatic, 
i.e., more individuals presented with NYHA functional class 
III/IV at baseline compared to married patients (69.7% vs. 
60.6%; P=0.009). Conversely, married patients had higher 
rates of previous clinical manifestation for coronary artery 
disease, previous myocardial infarction, previous percutaneous 
coronary intervention, as well as previous malignancy. 
While LVEF did not significantly differ between the groups, 
unmarried patients displayed smaller aortic valve areas.
Overall, procedures were performed under general 
anesthesia in 64.7% and balloon-expandable prostheses 
were deployed in 82.0% of cases. Device success was 
reached in 89.6% of cases and in-hospital mortality was 
1.4%. Procedural and in-hospital outcome showed no 
significant differences according to marital status and are 
displayed in Table 2.
Outcome at one year
At one year, all-cause mortality in the whole population 
Table 1 Baseline characteristics according to marital status
Characteristics
Married 
(N=442)
Unmarried 
(N=337)
P value
Age (years) 79.5±5.8 82.4±5.5 <0.001
Female gender, n (%) 125 (28.3) 247 (73.3) <0.001
Logistic EuroScore I (%) 11.7 
(7.0–18.5)
13.1  
(9.5–21.5)
<0.001
NYHA class III/IV, n (%) 268 (60.6) 235 (69.7) 0.009
COPD, n (%) 60 (13.6) 44 (13.1) 0.833
Diabetes mellitus, n (%) 138 (31.2) 85 (25.2) 0.066
Glomerular filtration rate  
(mL/min)
57±21 50±21 <0.001
Peripheral artery disease, n (%) 62 (14.0) 32 (9.5) 0.054
Previous stroke, n (%) 43 (9.7) 35 (10.4) 0.762
Coronary artery disease, n (%) 329 (74.4) 226 (67.1) 0.024
Previous myocardial infarction, 
n (%)
64 (14.5) 29 (8.6) 0.012
Previous PCI, n (%) 207 (46.8) 129 (38.3) 0.017
Previous CABG, n (%) 49 (11.1) 26 (7.7) 0.114
Previous SAVR, n (%) 11 (2.5) 10 (3.0) 0.683
Previous malignancy, n (%) 106 (24.0) 59 (17.5) 0.028
Previous pacemaker, n (%) 50 (11.3) 41 (12.2) 0.713
LV ejection fraction (%) 52.4±11.3 54.1±10.7 0.035
Aortic valve area (cm2) 0.76±0.20 0.70±0.19 <0.001
Mean transaortic gradient 43.4±14.8 45.0±16.5 0.189
Pulmonary hypertension*, n (%) 31 (7.0) 25 (7.4) 0.828
*, pulmonary arterial pressure ≥60 mmHg. NYHA, New York 
Heart Association functional class; COPD, chronic obstructive 
pulmonary disease; PCI, percutaneous coronary intervention; 
CABG, coronary artery bypass graft; SAVR, surgical aortic valve 
replacement; LV, left ventricular.
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was 10.5%. Table 3 displays outcomes at one year according 
to marital status. The unmarried population showed 
higher rates of the composite of cardiac death and CHF 
(18.7% vs. 12.0%; P=0.011; Figure 1A). While there was 
no difference in all-cause mortality (10.7% vs. 10.4%; 
P=0.879), unmarried patients more frequently experienced 
hospitalization for CHF at one year compared to married 
patients (14.1% vs. 7.8%; P=0.007). Figure 1B shows 
Kaplan-Meier survival curves for hospitalization for CHF 
according to marital status. Neither stroke rate nor the 
composite of death and stroke varied according to marital 
status (Figure 1C,D).
Results of the univariate and multivariate analyses 
for the primary endpoint are represented in Table 4. 
After multivariable adjustment, only NYHA class III/IV, 
peripheral artery disease and mean transaortic gradient 
persisted as independent predictors of the primary endpoint. 
Marital status was borderline significant with regard to 
CHF (HR 0.61; 95% CI: 0.37–1.02; P=0.06; Table 5) but 
not the primary endpoint (HR 0.73; 95% CI: 0.48–1.12; 
P=0.15).
Gender related outcome
Subgroup analyses were performed to assess gender-related 
differences in outcome after TAVI depending on marital 
status. Baseline characteristics and outcome according to 
marital status for each gender are shown in Table S1. While 
there were neither differences in baseline characteristics 
nor in outcomes according to marital status in the male 
population, significant differences were identified in 
women: unmarried female patients were older, had a higher 
preoperative risk score assessed by logistic EuroScore, 
worse renal function, and smaller aortic annuli compared to 
married patients. Rates of cardiac death or CHF (19.3% vs. 
10.5%; P=0.038) were higher in unmarried women during 
the first year after TAVI and this group more often required 
hospitalization for CHF during the first year after TAVI 
(14.5 vs. 5.9 %; P=0.022). 
A multivariate analysis was performed to identify 
independent risk predictors for the primary endpoint in both 
subgroups and is depicted in Tables S2 and S3 for women and 
men, respectively. For the female subgroup only previous 
dialysis, glomerular filtration rate and mean transvalvular 
gradients were predictors for the primary endpoint, while 
marital status showed no significant impact (HR 0.58; 95% 
CI: 0.29–1.18; P=0.14). In the male subgroup age, NYHA 
class III/IV and peripheral artery disease were independent 
predictors for the primary endpoint.
Regarding CHF, marital status in females persisted 
as independent predictor (HR 0.37; 95% CI: 0.14–0.96; 
P=0.04) along with older age, decreased glomerular 
filtration rate, smaller aortic valve area, lower transvalvular 
gradient and higher pulmonary pressure (Table S4). Marital 
status showed no significant association with the primary 
endpoint in the male subgroup (Table S5).
Discussion
To our knowledge, this is the first analysis investigating the 
association between marital status and outcome in patients 
undergoing TAVI. Compared to the married population, 
unmarried patients displayed a higher risk of cardiac death 
or CHF at one year after TAVI which was due to more 
Table 2 Procedural characteristics and in-hospital outcome 
according to marital status
Characteristics
Married 
(N=442)
Unmarried 
(N=337)
P 
value
General anaesthesia, n (%) 276 (62.4) 228 (67.7) 0.132
Balloon-expandable valve,  
n (%)
367 (83.0) 272 (80.7) 0.404
Procedural time (min) 65.6±34.5 65.5±30.7 0.930
Contrast (mL) 135.3±72.3 137.2±72.0 0.711
Fluoroscopy time (min) 14.6±8.2 14.5±6.9 0.914
Device success, n (%) 397 (89.8) 301 (89.3) 0.830
Days in hospital, n (%) 5 [4–7] 6 [5–8] 0.004
In-hospital mortality, n (%) 5 (1.1) 6 (1.8) 0.545
Table 3 One-year outcome according to marital status with 
Kaplan-Meier estimates
Variables
Married  
(n=442) (%)
Unmarried 
(n=337) (%)
P value
Cardiac death or CHF 52 (12.0) 62 (18.7) 0.011
Cardiac mortality 25 (5.8) 24 (7.3) 0.404
CHF 33 (7.8) 45 (14.1) 0.007
All-cause mortality 46 (10.4) 36 (10.7) 0.879
Stroke 26 (6.0) 16 (5.0) 0.543
Death or stroke 65 (14.7) 47 (14.0) 0.905
CHF, congestive heart failure.
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Figure 1 Kaplan-Meier survival curves for the composite of cardiac death and CHF (A), CHF (B), stroke (C), composite of death and stroke 
(D). CHF, congestive heart failure.
frequent hospitalizations for CHF. This effect was mainly 
driven by the outcome in female patients where marital 
status persisted as an independent factor of the primary 
endpoint even after multivariable adjustment.
In general, a trend towards lower rates of events in 
married patients has been observed in a variety of diseases. 
A study performed two decades ago in patients undergoing 
coronary artery bypass surgery revealed that married 
patients were 2.5 times more likely to be alive after 15 years 
compared to unmarried patients (13). Furthermore, a recent 
study in patients undergoing percutaneous revascularization 
also reported higher cardiovascular event rates in unmarried 
compared to married patients (14). Our results are in line 
with these studies showing that unmarried patients have 
higher event rates during the first year after TAVI.
The underlying reasons for an association between 
marital status and clinical outcomes remain speculative 
so far. An influence of psycho-social as well as biological 
factors has been postulated. Oncologists have reported 
higher rates of distress in unmarried patients (17). It is 
plausible, that this observation might not be restricted to 
patients suffering from cancer. Another important factor 
is that being unmarried might be associated with reduced 
social support. As a result, being married has been reported 
to be associated with a higher probability of medication 
adherence and a lower likelihood of smoking (18). As 
medication adherence was not investigated in this study, 
it was not possible to analyze whether this factor could be 
relevant in our population.
Another potential explanation is a confounding effect due 
to older age of unmarried, mostly widowed patients. In our 
cohort unmarried patients were older than married patients 
and furthermore displayed a higher operative risk in terms 
of a higher logistic EuroScore. Nevertheless, particularly in 
female patients, marital status persisted as an independent 
predictor of CHF, even after multivariable adjustment. 
Moreover, unmarried patients displayed smaller aortic valve 
areas and were more symptomatic which might be a result 
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Table 4 Univariate and multivariate analysis of predictors of cardiac death or CHF with variables selected by Lasso calibration method
Characteristics
Univariate Multivariate
HR (95% CI) P value HR (95% CI) P value
Married 0.62 (0.43–0.90) 0.01 0.73 (0.48–1.12) 0.15
Age (years) 1.07 (1.03–1.11) <0.001 1.02 (0.97–1.07) 0.43
Female gender 1.20 (0.83–1.74) 0.33
Logistic EuroScore I (%) 1.03 (1.02–1.04) <0.001 1.00 (0.98–1.02) 0.93
NYHA III or IV 2.66 (1.65–4.27) <0.001 1.69 (1.02–2.79) 0.040
COPD 1.53 (0.95–2.46) 0.078 1.34 (0.78–2.32) 0.29
Diabetes mellitus 1.36 (0.92–1.99) 0.12 1.28 (0.83–1.98) 0.26
Glomerular filtration rate (mL/min) 0.97 (0.96–0.99) <0.001 0.99 (0.98–1.00) 0.1
Peripheral vascular disease 2.14 (1.37–3.36) <0.001 2.00 (1.14–3.53) 0.02
Previous stroke 0.85 (0.44–1.62) 0.62 0.83 (0.43–1.61) 0.58
Coronary artery disease 1.33 (0.87–2.05) 0.19 1.18 (0.73–1.92) 0.49
Previous myocardial infarction 1.45 (0.87–2.39) 0.15
Previous PCI 1.07 (0.74–1.55) 0.71
Previous CABG 1.04 (0.56–1.94) 0.89
Previous SAVR 0.30 (0.04–2.17) 0.23 0 (∞) 0.96
Previous malignancy 0.73 (0.45–1.20) 0.22 0.88 (0.52–1.49) 0.63
Previous pacemaker 1.52 (0.92–2.51) 0.10
LV ejection fraction (%) 0.98 (0.97–0.99) 0.005 0.99 (0.98–1.01) 0.56
Aortic valve area (cm2) 0.45 (0.17–1.21) 0.11 0.39 (0.09–1.08) 0.07
Mean transaortic gradient 0.98 (0.97–0.99) 0.002 0.98 (0.96–0.99) 0.007
Pulmonary hypertension* 1.95 (1.11–3.40) 0.02 1.44 (0.73–2.84) 0.3
*, pulmonary arterial pressure ≥60 mmHg. HR, hazard ratio; NYHA, New York Heart Association functional class; COPD, chronic 
obstructive pulmonary disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; SAVR, surgical aortic valve 
replacement; LV, left ventricular.
of advanced disease due to late admission. Being married is 
likely associated with increased social support resulting in 
an earlier presentation at cardiology departments compared 
with unmarried counterparts lacking spouses recommending 
presentation. This hypothesis is further supported by the 
fact that adjusting for differences between the overall study 
groups resulted in loss of statistical significance although a 
trend towards lower incidence of the outcome persisted in 
married individuals.
Taken together, we conclude that unmarried patients 
undergoing TAVI are at higher risk for unfavorable 
outcomes during follow-up after TAVI. This may be due 
to an advanced disease status and lack of social support. 
Whether closer follow-up with enhanced medical care for 
unmarried patients improves clinical outcomes remains to 
be investigated.
Limitations
Albeit enrolling more than 700 patients and being the first 
analysis to assess the influence of marital status on clinical 
outcome after TAVI, this study has several limitations. 
First, this is a single center, retrospective, non-randomized 
study with intrinsic potential confounders. Mortality in the 
population with unknown marital status was significantly 
higher than in the study population (32.3% vs. 10.5%; 
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P<0.001), potentially suggesting a selection bias. Secondly, 
there are significant differences in baseline characteristics 
between the two groups, especially gender and age, which 
may have influenced the outcome. Thirdly, we only had 
access to information on marital status and relationships to 
partners; however we were unable to determine whether 
patients were living in nursing homes or with other close 
family members, e.g., children. Finally, we did not have 
information about changes in marital status during time of 
follow-up. Thus, we cannot exclude that changes in marital 
status might have influenced the outcome.
Conclusions
This first analysis on the influence of marital status on 
outcome after TAVI revealed that, albeit not being an 
independent predictor, unmarried patients are at higher 
risk for hospitalization for CHF at one year after TAVI. 
Although this study has some limitations, these results 
indicate that, similar to other cardiovascular procedures, 
unmarried patients might demand more intensive 
medical care than married patients. Whether intensified 
management of unmarried patients is able to improve 
outcomes remains unknown.
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Supplementary
Table S1 Baseline characteristics and outcome according to marital status for gender subgroups
Characteristics
Women (n=372) Men (n=407)
Married (n=125) Unmarried (n=247) P value Married (n=317) Unmarried (n=90) P value
Age (years) 78.9±6.3 83.1±5.0 <0.001 79.7±5.6 80.7±6.4 0.14
Logistic EuroScore I (%) 11.9 (7.0–17.5) 13.6 (10.1–21.5) <0.001 11.6 (7.0–18.8) 12.1 (8.4–20.6) 0.46
NYHA III or IV, n (%) 80 (64.0) 179 (72.5) 0.09 188 (59.3) 56 (62.2) 0.62
COPD, n (%) 12 (9.6) 30 (12.1) 0.46 48 (15.1) 14 (15.6) 0.92
Diabetes mellitus, n (%) 29 (23.2) 57 (23.1) 0.98 109 (34.4) 28 (31.1) 0.56
On dialysis, n (%) 0 (0) 1 (0.4) 0.99 5 (1.6) 0 (0) 0.59
Glomerular filtration rate (mL/min) 52.8±18.9 46.6±19.1 0.003 58.7±21.5 59.0±21.9 0.9
Peripheral vascular disease, n (%) 18 (14.4) 21 (8.5) 0.08 44 (13.9) 11 (12.2) 0.69
Previous stroke, n (%) 13 (10.4) 23 (9.3) 0.74 30 (9.5) 12 (13.3) 0.29
Coronary artery disease, n (%) 73 (58.4) 155 (62.8) 0.46 256 (80.8) 71 (78.9) 0.69
Previous myocardial infarction, n (%) 7 (5.6) 18 (7.3) 0.539 57 (18.0) 11 (12.2) 0.2
Previous CABG, n (%) 8 (6.4) 15 (6.1) 0.90 41 (12.9) 11 (12.2) 0.86
Previous SAVR, n (%) 3 (2.4) 9 (3.6) 0.76 8 (2.5) 1 (1.1) 0.42
Previous carcinoma, n (%) 28 (22.4) 38 (15.4) 0.09 78 (24.6) 21 (23.3) 0.80
LV ejection fraction (%) 55.6±8.7 55.1±9.8 0.66 51.1±11.9 51.2±12.4 0.94
Aortic valve area (cm2) 0.71±0.24 0.66±0.18 0.01 0.78±0.18 0.80±0.19 0.20
Mean transaortic gradient 46.0±15.4 46.7±17.2 0.69 42.5±14.5 40.2±13.5 0.2
Pulmonary hypertension*, n (%) 5 (4.0) 21 (8.5) 0.11 26 (8.2) 4 (4.4) 0.23
One year outcome, n (%)
Cardiac death or CHF 13 (10.5) 47 (19.3) 0.04 39 (12.6) 15 (16.9) 0.27
Cardiac mortality 8 (6.4) 19 (7.8) 0.61 17 (5.5) 5 (5.8) 0.79
CHF 7 (5.9) 34 (14.5) 0.02 26 (8.6) 11 (12.8) 0.23
All-cause mortality 11 (8.8) 23 (9.4) 0.72 35 (11.1) 13 (14.4) 0.36
Stroke 8 (6.7) 13 (5.7) 0.71 18 (5.8) 3 (3.5) 0.38
Death/stroke 15 (12.3) 31 (13.2) 0.74 45 (14.4) 15 (16.9) 0.58
*, pulmonary arterial pressure ≥60 mmHg. NYHA, New York Heart Association functional class; COPD, chronic obstructive pulmonary 
disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; SAVR, surgical aortic valve replacement; LV, left 
ventricular; CHF, congestive heart failure.
Table S2 Multivariate Analysis of predictors of cardiac death or 
CHF with variables selected by Lasso calibration method in the 
female subgroup
Characteristics HR (95% CI) P value
Married 0.58 (0.29–1.18) 0.14
NYHA III/IV 1.52 (0.72–1.18) 0.27
Diabetes mellitus 1.62 (0.88–2.96) 0.12
Previous dialysis 12.4 (1.27–120.71) 0.03
Glomerular filtration rate (mL/min) 0.98 (0.96–1.00) 0.05
Coronary artery disease 1.30 (0.70–2.41) 0.4
Previous myocardial infarction 0.86 (0.3–2.49) 0.78
Previous CABG 0.22 (0.03–1.61) 0.14
Previous aortic valve replacement 0 (∞) 0.97
LV ejection fraction (%) 0.99 (0.96–1.01) 0.27
Aortic valve area 0.37 (0.07–2.11) 0.27
Mean transvalvular gradient 0.98 (0.95–0.99) 0.04
Pulmonary hypertension * 1.79 (0.82–3.89) 0.14
*, pulmonary arterial pressure ≥60 mmHg. CHF, congestive heart 
failure; NYHA, New York Heart Association functional class; 
CABG, coronary artery bypass graft; LV, left ventricular.
Table S3 Multivariate Analysis of predictors of cardiac death or 
CHF with variables selected by Lasso calibration method in the 
male subgroup
Characteristics HR (95% CI) P value
Married 0.89 (0.46–1.70) 0.72
Age 1.08 (1.01–1.14) 0.02
EuroScore I 1.02 (0.99–1.05) 0.13
NYHA III/IV 2.03 (1.03–3.99) 0.04
COPD 1.53 (0.76–3.05) 0.23
Previous dialysis 3.35 (0.58–19.54) 0.18
Glomerular filtration rate (mL/min) 0.99 (0.98–1.02) 0.87
Peripheral artery disease 3.06 (1.62–5.81) 0.001
Aortic valve area 0.4 (0.07–2.13) 0.28
*, pulmonary arterial pressure ≥60 mmHg. CHF, congestive heart 
failure; NYHA, New York Heart Association functional class.
Table S4 Multivariate Analysis of predictors of CHF with variables 
selected by Lasso calibration method in the female subgroup
Characteristics HR (95% CI) P value
Married 0.37 (0.14–0.96) 0.04
Age 0.91 (0.84–0.99) 0.03
NYHA III/IV 1.36 (0.56–3.34) 0.5
COPD 1.49 (0.6–3.71) 0.39
Diabetes mellitus 1.37 (0.66–2.87) 0.4
Previous dialysis 0 (∞) 0.99
Glomerular filtration rate (mL/min) 0.97 (0.94–0.99) 0.02
Peripheral artery disease 0.62 (0.17–2.21) 0.46
Previous stroke 0.81 (0.28–2.36) 0.7
Coronary artery disease 1.22 (0.6–2.5) 0.59
Previous CABG 0 (∞) 0.98
Previous aortic valve replacement 0 (∞) 0.99
Previous malignancy 0.73 (0.28–1.90) 0.51
LV ejection fraction (%) 0.99 (0.96–1.03) 0.73
Aortic valve area 0.11 (0.01–0.93) 0.04
Mean transvalvular gradient 0.96 (0.93–0.99) 0.008
Pulmonary hypertension* 3.25 (1.34–7.9) 0.009
*, pulmonary arterial pressure ≥60 mmHg. CHF, congestive heart 
failure; NYHA, New York Heart Association functional class; 
CABG, coronary artery bypass graft; LV, left ventricular.
Table S5 Multivariate analysis of predictors of CHF with variables 
selected by Lasso calibration method in the male subgroup
Characteristics HR (95% CI) P value
Married 0.79 (0.37–1.69) 0.54
Age 1.09 (1.01–1.16) 0.019
Logistic EuroScore I (%) 1.01 (0.97–1.05) 0.66
NYHA III/IV 2.48 (1.05–5.86) 0.04
COPD 1.33 (0.56–3.13) 0.52
Peripheral artery disease 5.36 (2.55–11.26) <0.001
LV ejection fraction (%) 0.97 (0.95–1.00) 0.07
Aortic valve area 0.30 (0.04–2.27) 0.25
*, pulmonary arterial pressure ≥60 mmHg. CHF, congestive 
heart failure; NYHA, New York Heart Association functional 
class; COPD, chronic obstructive pulmonary disease; LV, left 
ventricular.
